• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症治愈的精细化途径研究路线图。

The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.

机构信息

National Multiple Sclerosis Society, New York, NY, USA.

Division of Child Neurology, Children's Hospital of Philadelphia, Departments of Neurology and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Mult Scler. 2024 Sep;30(10):1242-1251. doi: 10.1177/13524585241266483. Epub 2024 Aug 30.

DOI:10.1177/13524585241266483
PMID:39212108
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11451078/
Abstract

BACKGROUND

Multiple sclerosis is a chronic immune-mediated disease of the central nervous system affecting nearly 3 million people worldwide. Although much progress has been made in the understanding and treatment of MS, cures remain elusive.

OBJECTIVES

To accelerate the development of cures for MS by updating the Pathways to Cures Research Roadmap based on a contemporary understanding of disease. The refined Roadmap will help to promote research in scientific areas with great potential to reveal insights leading to cures and inspire greater coordination of global resources.

METHODS

Refinements to the Roadmap were achieved during a Global Summit that included close to 200 academic and industry scientists, health care providers, policy makers, funders, and people with MS from 15 countries.

RESULTS

The refined Roadmap describes three pathways that target opportunities for generating scientific insights leading to cures. Recommendations for accelerating research progress include, lowering barriers for global data sharing, enhancing collaboration and coordination among research supporters, committing to sustained funding, considering implications for implementation, engaging PwMS and committing to diversity, equity, and inclusion in the global MS movement.

CONCLUSION

The refined roadmap provides a strategic framework for tackling the complexities of MS and advancing prevention strategies, effective treatments, and cures.

摘要

背景

多发性硬化症是一种影响全球近 3000 万人的中枢神经系统慢性免疫介导疾病。尽管人们对多发性硬化症的认识和治疗已经取得了很大的进展,但治愈方法仍难以捉摸。

目的

通过更新基于对疾病的当代理解的“治愈途径研究路线图”,加速多发性硬化症的治愈方法的开发。经过精炼的路线图将有助于促进具有巨大潜力的科学领域的研究,这些研究有可能揭示导致治愈的见解,并激发全球资源更大程度的协调。

方法

在一次全球峰会上对路线图进行了改进,该峰会有来自 15 个国家的近 200 名学术和行业科学家、医疗保健提供者、政策制定者、资助者以及多发性硬化症患者参加。

结果

精炼后的路线图描述了三条针对产生导致治愈的科学见解的机会的途径。加速研究进展的建议包括降低全球数据共享的障碍,加强研究支持者之间的合作与协调,承诺持续提供资金,考虑实施的影响,让患者参与并承诺在全球多发性硬化症运动中实现多样性、公平性和包容性。

结论

经过精炼的路线图为应对多发性硬化症的复杂性以及推进预防策略、有效治疗方法和治愈方法提供了一个战略框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d9/11451078/1d8236eea394/10.1177_13524585241266483-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d9/11451078/59e08b16a535/10.1177_13524585241266483-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d9/11451078/1d8236eea394/10.1177_13524585241266483-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d9/11451078/59e08b16a535/10.1177_13524585241266483-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91d9/11451078/1d8236eea394/10.1177_13524585241266483-fig2.jpg

相似文献

1
The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.多发性硬化症治愈的精细化途径研究路线图。
Mult Scler. 2024 Sep;30(10):1242-1251. doi: 10.1177/13524585241266483. Epub 2024 Aug 30.
2
Pathways to cures for multiple sclerosis: A research roadmap.多发性硬化症的治疗途径:研究路线图。
Mult Scler. 2022 Mar;28(3):331-345. doi: 10.1177/13524585221075990.
3
The first global landscape analysis of multiple sclerosis research funding.第一篇多发性硬化症研究资金的全球全景分析。
Mult Scler. 2024 Sep;30(10):1363-1369. doi: 10.1177/13524585241265961. Epub 2024 Jul 31.
4
A research roadmap for complementary and alternative medicine - what we need to know by 2020.补充和替代医学研究路线图——到2020年我们需要了解的内容。
Forsch Komplementmed. 2014;21(2):e1-16. doi: 10.1159/000360744. Epub 2014 Mar 24.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Tuberculosis结核病
7
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
8
Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020.加速癌症护理研究进展:2020 年回顾 21 世纪治愈法案。
J Natl Compr Canc Netw. 2021 Apr 1;19(4):378-384. doi: 10.6004/jnccn.2021.7005. Print 2021 Apr.
9
Engaging a community to focus on upper limb function in people with multiple sclerosis: the ThinkHand campaign case study.动员社区关注多发性硬化症患者的上肢功能:“思考手部”运动案例研究
Res Involv Engagem. 2024 Jun 18;10(1):62. doi: 10.1186/s40900-024-00586-y.
10
Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.确定多发性硬化症中未解决的问题并为未来的系统研究设定议程。一项全球多利益相关方的优先级设定项目。
Mult Scler Relat Disord. 2022 Apr;60:103688. doi: 10.1016/j.msard.2022.103688. Epub 2022 Feb 22.

引用本文的文献

1
High-risk populations should be screened for MS: Yes.高危人群应进行MS筛查:是。
Mult Scler. 2025 Aug;31(9):1032-1034. doi: 10.1177/13524585251353044. Epub 2025 Jul 8.

本文引用的文献

1
An autoantibody signature predictive for multiple sclerosis.一种预测多发性硬化症的自身抗体特征。
Nat Med. 2024 May;30(5):1300-1308. doi: 10.1038/s41591-024-02938-3. Epub 2024 Apr 19.
2
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.高维血液特征识别的多发性硬化症内表型与不同的疾病轨迹相关。
Sci Transl Med. 2024 Mar 27;16(740):eade8560. doi: 10.1126/scitranslmed.ade8560.
3
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold.
理解多发性硬化症作为一种疾病谱:临床阈值以上和以下。
Curr Opin Neurol. 2024 Jun 1;37(3):189-201. doi: 10.1097/WCO.0000000000001262. Epub 2024 Apr 9.
4
Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment.评估复发性缓解型多发性硬化症病灶修复的可行性研究:多潘立酮附加治疗的随机对照试验。
Mult Scler Relat Disord. 2024 May;85:105525. doi: 10.1016/j.msard.2024.105525. Epub 2024 Feb 27.
5
Rheumatoid arthritis: prediction of future clinically-apparent disease, and prevention.类风湿关节炎:未来临床明显疾病的预测和预防。
Curr Opin Rheumatol. 2024 May 1;36(3):225-234. doi: 10.1097/BOR.0000000000001013. Epub 2024 Mar 5.
6
Disentangling multiple sclerosis phenotypes through Mendelian disorders: A network approach.通过孟德尔疾病解析多发性硬化症表型:一种网络方法。
Mult Scler. 2024 Mar;30(3):325-335. doi: 10.1177/13524585241227119. Epub 2024 Feb 9.
7
The Journey of Data Within a Global Data Sharing Initiative: A Federated 3-Layer Data Analysis Pipeline to Scale Up Multiple Sclerosis Research.全球数据共享倡议中的数据之旅:用于扩大多发性硬化症研究规模的联合三层数据分析管道
JMIR Med Inform. 2023 Nov 9;11:e48030. doi: 10.2196/48030.
8
Radiologically isolated syndrome.孤立综合征(Radiologically isolated syndrome)。
Lancet Neurol. 2023 Nov;22(11):1075-1086. doi: 10.1016/S1474-4422(23)00281-8. Epub 2023 Oct 12.
9
Exchanging words: Engaging the challenges of sharing qualitative research data.交流观点:应对分享定性研究数据的挑战
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2206981120. doi: 10.1073/pnas.2206981120. Epub 2023 Oct 13.
10
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial.认知康复和有氧运动治疗进展性多发性硬化认知障碍(CogEx):一项随机、盲法、假手术对照试验。
Lancet Neurol. 2023 Oct;22(10):912-924. doi: 10.1016/S1474-4422(23)00280-6.